Julia Strandberg

Insider Reports History

Location
Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julia Strandberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 1,409,523 15 Feb 2023 Direct

Insider Reports Filed by Julia Strandberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299323004041-strandberg-julia-2023-02-15 Pear Therapeutics, Inc. 15 Feb 2023 1 $0 4 Chief Commercial Officer 17 Feb 2023, 15:13
/report/000106299323001328-strandberg-julia-2023-01-20 Pear Therapeutics, Inc. 20 Jan 2023 1 -$14,337 4 Chief Commercial Officer 24 Jan 2023, 15:08
/report/000106299323001036-strandberg-julia-2023-01-14 Pear Therapeutics, Inc. 14 Jan 2023 2 $0 4 Chief Commercial Officer 18 Jan 2023, 16:01
/report/000106299322004980-strandberg-julia-2022-02-16 Pear Therapeutics, Inc. 16 Feb 2022 2 $0 4 Chief Commercial Officer 18 Feb 2022, 15:42
/report/000106299321012400-strandberg-julia-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 3 $0 4 Chief Commercial Officer 07 Dec 2021, 16:26
/report/000106299321012360-strandberg-julia-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 0 $0 3 Chief Commercial Officer 07 Dec 2021, 16:07